April 14, 2026 News
Anthropic Briefs Trump Administration on Unreleased Mythos AI Model with Advanced Cybersecurity Capabilities
Anthropic co-founder Jack Clark confirmed the company briefed the Trump administration on its new Mythos AI model, which possesses powerful cybersecurity capabilities deemed too dangerous for public release. This engagement occurs despite Anthropic's ongoing lawsuit against the Department of Defense over restrictions on military access to its AI systems. The company is also monitoring potential AI-driven employment impacts, particularly in early graduate employment across select industries.
Skynet Chance (+0.09%): The development of AI capabilities so dangerous they cannot be publicly released, combined with potential military applications and cybersecurity exploitation capabilities, significantly increases risks of AI systems being weaponized or causing unintended harm. The tension between private AI development and government military access creates additional scenarios for loss of control.
Skynet Date (-1 days): The existence of AI models with advanced cybersecurity capabilities that are already being briefed to government and financial institutions suggests accelerated development of potentially dangerous AI capabilities. The company's simultaneous development of such systems while expressing concerns about employment impacts indicates rapid capability advancement.
AGI Progress (+0.06%): The development of Mythos with capabilities considered too dangerous for public release indicates significant advancement in AI capabilities, particularly in complex domains like cybersecurity that require sophisticated reasoning and adaptation. The model's power level suggests substantial progress toward more general and capable AI systems.
AGI Date (-1 days): Anthropic's rapid development of increasingly powerful models, combined with CEO warnings about Depression-era unemployment levels and observable impacts on graduate employment, indicates faster-than-expected progress toward AGI-level capabilities. The company's preparation for major employment shifts suggests they anticipate transformative AI capabilities arriving sooner than public expectations.
Science Corp. Advances Biohybrid Brain-Computer Interface Toward First Human Trials
Science Corporation, founded by former Neuralink president Max Hodak, is preparing to conduct first US human trials of a biohybrid brain-computer interface that combines lab-grown neurons with electronics. The company has recruited Yale neurosurgeon Dr. Murat Günel to lead trials of an advanced sensor that will rest on the brain's surface, with initial tests planned for patients already requiring brain surgery. Unlike conventional electrode-based BCIs, this approach aims to create biological integration between electronics and the brain to treat neurological conditions and potentially enable human enhancement.
Skynet Chance (+0.04%): The development of biohybrid interfaces that integrate lab-grown neurons with electronics represents a novel pathway for brain-computer integration with potentially more durable and sophisticated control mechanisms. While currently focused on medical applications, the explicit goal of human enhancement and adding new senses introduces alignment challenges around augmented cognitive capabilities.
Skynet Date (+0 days): This represents an alternative technological pathway to brain-computer interfaces that may take longer to mature than conventional electrode approaches, slightly delaying potential risks. However, if successful, biological integration could ultimately enable more powerful human-AI coupling than current methods.
AGI Progress (+0.03%): Biohybrid brain-computer interfaces could enable more sophisticated bidirectional communication between biological and artificial intelligence systems, representing progress toward tighter integration of human cognition with AI. The biological approach may overcome limitations of electrode-based systems and enable more complex neural interfacing crucial for AGI-human collaboration.
AGI Date (+0 days): The $1.5 billion valuation and $230 million funding, combined with concrete plans for human trials by 2027, accelerates development of advanced brain-computer interfaces. This technology could speed pathways to AGI by enabling direct neural interfaces for AI systems to interact with human intelligence and learn from biological neural processing.